Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
J. Brooks Jackson(VA Tennessee Valley Healthcare System), Francis Mmiro(Makerere University), Corey Duefield(Johns Hopkins University), Maria Gigliotti(Boehringer Ingelheim (Germany)), Joseph Sherman(Johns Hopkins University), Melissa Allen(Family Health International 360), Anthony Mwatha(Fred Hutch Cancer Center), Lynda Emel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Philippa Musoke(Centers for Disease Control and Prevention), Maxensia Owor(Makerere University), Danstan Bagenda(Makerere University), Martina Deseyve(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Thomas R. Fleming(University of Washington), Paul Bakaki(Makerere University), Mary Glenn Fowler(Johns Hopkins University), Dorothy Bray(Wellcome Library), Clemensia Nakabiito(Makerere University), Mark Mirochnick(Boston University), Laura Guay(Johns Hopkins University), Paolo Miotti(Office of AIDS Research), Constance Ducar(Fred Hutch Cancer Center)
Cited by 525
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure
|Circulation|2004|1.2k